Related references
Note: Only part of the references are listed.Current understanding and future implications of sepsis-induced thrombocytopenia
Subash Ghimire et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2021)
Effects of Thrombomodulin in Reducing Lethality and Suppressing Neutrophil Extracellular Trap Formation in the Lungs and Liver in a Lipopolysaccharide-Induced Murine Septic Shock Model
Yu Kato et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Review: The Emerging Role of Neutrophil Extracellular Traps in Sepsis and Sepsis-Associated Thrombosis
Zhaoyuan Chen et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
Endotheliopathy in septic conditions: mechanistic insight into intravascular coagulation
Takashi Ito et al.
CRITICAL CARE (2021)
Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation
Toshiaki Iba et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2020)
Revisiting the Protein C Pathway: An Opportunity for Adjunctive Intervention in COVID-19?
Michael Mazzeffi et al.
ANESTHESIA AND ANALGESIA (2020)
Prognosis and rescue therapy for sepsis-related severe thrombocytopenia in critically ill patients
Zhigang Zhou et al.
CYTOKINE (2020)
War to the knife against thromboinflammation to protect endothelial function of COVID-19 patients
Gabriele Guglielmetti et al.
CRITICAL CARE (2020)
Significance of plasma fibrinogen level and antithrombin activity in sepsis: A multicenter cohort study using a cubic spline model
Tsunehiro Matsubara et al.
THROMBOSIS RESEARCH (2019)
Recombinant Thrombomodulin Suppresses Histone-Induced Neutrophil Extracellular Trap Formation
Binita Shrestha et al.
FRONTIERS IN IMMUNOLOGY (2019)
Effects of Serum Albumin Levels on Antithrombin Supplementation Outcomes Among Patients With Sepsis-Associated Coagulopathy: A Retrospective Study
Masatomo Ebina et al.
CLINICAL MEDICINE INSIGHTS-BLOOD DISORDERS (2019)
Thrombomodulin in disseminated intravascular coagulation and other critical conditions-a multi-faceted anticoagulant protein with therapeutic potential
Takashi Ito et al.
CRITICAL CARE (2019)
Concomitant Versus Individual Administration of Antithrombin and Thrombomodulin for Sepsis-Induced Disseminated Intravascular Coagulation: A Nationwide Japanese Registry Study
Yutaka Umemura et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2018)
Circulating activated protein C levels are not increased in septic patients treated with recombinant human soluble thrombomodulin
Takuro Arishima et al.
THROMBOSIS JOURNAL (2018)
Secondary thrombotic microangiopathies
P. Coppo
REVUE DE MEDECINE INTERNE (2017)
Effects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation
Toshiaki Iba et al.
ANNALS OF INTENSIVE CARE (2017)
Is Thrombocytopenia an Early Prognostic Marker in Septic Shock?
Nadiejda Thiery-Antier et al.
CRITICAL CARE MEDICINE (2016)
Thrombocytopenia is associated with a dysregulated host response in critically ill sepsis patients
Theodora A. M. Claushuis et al.
BLOOD (2016)
The efficacy and safety of antithrombin and recombinant human thrombomodulin combination therapy in patients with severe sepsis and disseminated intravascular coagulation
Norihisa Yasuda et al.
JOURNAL OF CRITICAL CARE (2016)
Thrombocytopenia in critically ill patients with severe sepsis/septic shock: Prognostic value and association with a distinct serum cytokine profile
Panagiotis Tsirigotis et al.
JOURNAL OF CRITICAL CARE (2016)
Recombinant human thrombomodulin inhibits neutrophil extracellular trap formation in vitro
Yasuyo Shimomura et al.
JOURNAL OF INTENSIVE CARE (2016)
Recombinant human soluble thrombomodulin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study
T. Tagami et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Thrombocytopenia impairs host defense in gram-negative pneumonia-derived sepsis in mice
Sacha F. de Stoppelaar et al.
BLOOD (2014)
Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study
T. Tagami et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Post-marketing surveillance data of thrombomodulin alfa: sub-analysis in patients with sepsis-induced disseminated intravascular coagulation
Yutaka Eguchi et al.
JOURNAL OF INTENSIVE CARE (2014)
Impact of recombinant soluble thrombomodulin (thrombomodulin alfa) on disseminated intravascular coagulation
Jun Mimuro et al.
THROMBOSIS RESEARCH (2013)
Thrombosis as an intravascular effector of innate immunity
Bernd Engelmann et al.
NATURE REVIEWS IMMUNOLOGY (2013)
The Frequency and Clinical Significance of Thrombocytopenia Complicating Critical Illness A Systematic Review
Phil Hui et al.
CHEST (2011)
Combination effect of antithrombin and recombinant human soluble thrombomodulin in a lipopolysaccharide induced rat sepsis model
Toshiaki Iba et al.
CRITICAL CARE (2009)
The Role of Natural Anticoagulants in the Pathogenesis and Management of Systemic Activation of Coagulation and Inflammation in Critically Ill Patients
Marcel Levi et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2008)
Clinical review: Molecular mechanisms underlying the role of antithrombin in sepsis
Christian J. Wiedermann
CRITICAL CARE (2006)
Predictive value of antithrombin III and serum C-reactive protein concentration in critically ill patients with suspected sepsis
V Pettilä et al.
CRITICAL CARE MEDICINE (2002)
Decreased plasma activity of antithrombin or protein C is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation
H Asakura et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2001)
Share Paper
